2-[4-Hydroxy-2-(hydroxymethyl)-6-(5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-16-yl)oxy-5-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol

Details

Top
Internal ID 51af958c-313a-4373-81ea-e81ec29bac65
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroidal glycosides > Steroidal saponins
IUPAC Name 2-[4-hydroxy-2-(hydroxymethyl)-6-(5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-16-yl)oxy-5-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol
SMILES (Canonical) CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)C)O)O)O)O)OC9C(C(C(C(O9)C)O)O)O)C)C)C)OC1
SMILES (Isomeric) CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)C)O)O)O)O)OC9C(C(C(C(O9)C)O)O)O)C)C)C)OC1
InChI InChI=1S/C45H72O16/c1-19-9-14-45(54-18-19)20(2)30-28(61-45)16-27-25-8-7-23-15-24(10-12-43(23,5)26(25)11-13-44(27,30)6)57-42-39(60-41-36(52)34(50)32(48)22(4)56-41)37(53)38(29(17-46)58-42)59-40-35(51)33(49)31(47)21(3)55-40/h7,19-22,24-42,46-53H,8-18H2,1-6H3
InChI Key VNONINPVFQTJOC-UHFFFAOYSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C45H72O16
Molecular Weight 869.00 g/mol
Exact Mass 868.48203620 g/mol
Topological Polar Surface Area (TPSA) 236.00 Ų
XlogP 1.30
Atomic LogP (AlogP) 1.24
H-Bond Acceptor 16
H-Bond Donor 8
Rotatable Bonds 7

Synonyms

Top
2-[4-Hydroxy-2-(hydroxymethyl)-6-(5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-16-yl)oxy-5-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol
DTXSID20975887
BCP10401
NSC115920
NSC-115920
spirost-5-en-3-yl 6-deoxyhexopyranosyl-(1->2)-[6-deoxyhexopyranosyl-(1->4)]hexopyranoside
LS-15467
L023969
Collettiside III; CCRIS 4123;Saponin; CCRIS4123; CCRIS-4123

2D Structure

Top
2D Structure of 2-[4-Hydroxy-2-(hydroxymethyl)-6-(5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-16-yl)oxy-5-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.6670 66.70%
Caco-2 - 0.8889 88.89%
Blood Brain Barrier - 0.6000 60.00%
Human oral bioavailability - 0.7857 78.57%
Subcellular localzation Mitochondria 0.7312 73.12%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9018 90.18%
OATP1B3 inhibitior + 0.9077 90.77%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.6000 60.00%
BSEP inhibitior + 0.9143 91.43%
P-glycoprotein inhibitior + 0.7236 72.36%
P-glycoprotein substrate - 0.5313 53.13%
CYP3A4 substrate + 0.7451 74.51%
CYP2C9 substrate - 0.8054 80.54%
CYP2D6 substrate - 0.8216 82.16%
CYP3A4 inhibition - 0.9365 93.65%
CYP2C9 inhibition - 0.9317 93.17%
CYP2C19 inhibition - 0.9163 91.63%
CYP2D6 inhibition - 0.9298 92.98%
CYP1A2 inhibition - 0.8611 86.11%
CYP2C8 inhibition + 0.7425 74.25%
CYP inhibitory promiscuity - 0.8619 86.19%
UGT catelyzed - 0.7000 70.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.4702 47.02%
Eye corrosion - 0.9888 98.88%
Eye irritation - 0.9148 91.48%
Skin irritation - 0.5365 53.65%
Skin corrosion - 0.9419 94.19%
Ames mutagenesis - 1.0000 100.00%
Human Ether-a-go-go-Related Gene inhibition + 0.7706 77.06%
Micronuclear - 0.8700 87.00%
Hepatotoxicity - 1.0000 100.00%
skin sensitisation - 0.9151 91.51%
Respiratory toxicity + 0.7667 76.67%
Reproductive toxicity + 0.8111 81.11%
Mitochondrial toxicity - 0.5375 53.75%
Nephrotoxicity - 0.7905 79.05%
Acute Oral Toxicity (c) III 0.4854 48.54%
Estrogen receptor binding + 0.8558 85.58%
Androgen receptor binding + 0.7112 71.12%
Thyroid receptor binding - 0.5615 56.15%
Glucocorticoid receptor binding + 0.5403 54.03%
Aromatase binding + 0.6737 67.37%
PPAR gamma + 0.7365 73.65%
Honey bee toxicity - 0.5545 55.45%
Biodegradation - 0.8000 80.00%
Crustacea aquatic toxicity - 0.5300 53.00%
Fish aquatic toxicity + 0.9347 93.47%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 98.69% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.20% 91.11%
CHEMBL226 P30542 Adenosine A1 receptor 97.04% 95.93%
CHEMBL3137262 O60341 LSD1/CoREST complex 94.48% 97.09%
CHEMBL1994 P08235 Mineralocorticoid receptor 93.56% 100.00%
CHEMBL1806 P11388 DNA topoisomerase II alpha 91.47% 89.00%
CHEMBL4681 P42330 Aldo-keto-reductase family 1 member C3 91.44% 89.05%
CHEMBL5608 Q16288 NT-3 growth factor receptor 89.98% 95.89%
CHEMBL253 P34972 Cannabinoid CB2 receptor 89.96% 97.25%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 89.80% 95.89%
CHEMBL1914 P06276 Butyrylcholinesterase 89.74% 95.00%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 87.04% 94.45%
CHEMBL218 P21554 Cannabinoid CB1 receptor 85.62% 96.61%
CHEMBL1293249 Q13887 Kruppel-like factor 5 85.51% 86.33%
CHEMBL4187 Q99250 Sodium channel protein type II alpha subunit 85.40% 95.50%
CHEMBL5255 O00206 Toll-like receptor 4 85.34% 92.50%
CHEMBL332 P03956 Matrix metalloproteinase-1 84.52% 94.50%
CHEMBL2274 Q9H228 Sphingosine 1-phosphate receptor Edg-8 83.92% 100.00%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 82.50% 94.00%
CHEMBL237 P41145 Kappa opioid receptor 81.49% 98.10%
CHEMBL2581 P07339 Cathepsin D 81.04% 98.95%
CHEMBL2373 P21730 C5a anaphylatoxin chemotactic receptor 80.99% 92.62%
CHEMBL2288 Q13526 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 80.74% 91.71%
CHEMBL3430907 Q96GD4 Aurora kinase B/Inner centromere protein 80.44% 97.50%

Cross-Links

Top
PubChem 271916
LOTUS LTS0044633
wikiData Q72472636